Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
6.405 / 17.033
#51234

Re: Farmas USA

Si, pero en nuestras farmas no se nota...jeje

#51235

Re: Farmas USA

SNTA

No es que este parada es que esta haciendo un suelo jejeje

#51238

Re: Farmas USA

BAXS
Directamente al infierno y no encuentro el por que de esta bajada tan brutal en dos días

#51239

Re: Farmas USA

FDA http://news.msn.com/us/anti-addiction-groups--for-new-fda-chief WASHINGTON (AP) — Anti-addiction activists are calling for the Food and Drug Administration's top official to step down, saying the agency's policies have contributed to a national epidemic of prescription painkiller abuse. In a letter released Wednesday, more than a dozen groups ask the Obama administration's top health official to replace FDA Commissioner Dr. Margaret Hamburg, who has led the agency since 2009. The FDA has been under fire from public health advocates, politicians and law enforcement officials since last October, when it approved a powerful new painkiller called Zohydro against the recommendation of its own medical advisers. The new letter is the first formal call for new leadership at the FDA over the issue. "We are especially frustrated by the FDA's continued approval of new, dangerous, high-dose opioid analgesics that are fueling high rates of addiction and overdose deaths," states the letter, which is addressed to Health and Human Services Secretary Sylvia Burwell, who oversees the FDA and other health agencies. The groups signing the letter include Physicians for Responsible Opioid Prescribing, a 900-member advocacy group that petitioned the FDA to drastically restrict opioid use. The FDA rejected that petition last year.

FDA Commissioner Dr. Margaret A. Bitch Hamburg poses for a portrait before a newsmaker interview at the Associated Press in Washington

#51240

Re: Farmas USA

Jajaja. Muy apropiada la negrita.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

Te puede interesar...
  1. Inflación y tipos en el punto de mira, la historia no se repite pero rima
  2. La Euforia Post-Trump: ¿Calma o Tormenta en el Mercado?